Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Schering acquisition boosts Bayer’s 2006 turnover figures

March 22, 2007 Sales and Marketing

Bayer HealthCare's turnover rose 46% to €11.7 billion on the back of Bayer Group's acquisition of Schering last year. As …
News

Servier “named and shamed” for sales slides

March 21, 2007 Sales and Marketing ethics

Servier has been publicly "named and shamed" for using inappropriate materials to train its sales reps.Servier and another company, Shire …
News

Schering-Plough to buy Organon for 11 billion euros

March 21, 2007 Sales and Marketing Merck, Schering-Plough

Schering-Plough is to buy Organon BioSciences by the end of this year, in an €11 billion cash deal.The acquisition will …
News

Abbott withdraws HIV drugs from Thailand after patent row

March 21, 2007 Sales and Marketing HIV

Abbott Laboratories' tit-for-tat decision to withold new HIV treatments from Thailand has drawn an angry response from the Aids Healthcare …
News

E-marketing has arrived…but not everyone has noticed

March 19, 2007 Medical Communications, Sales and Marketing e-marketing, marketing, new media

Feature

Tyverb gains first approval in US

March 14, 2007 Sales and Marketing breast cancer

GlaxoSmithKline's breast cancer drug, Tyverb, has been approved in the US and could help women who have failed to respond …
News

New diabetes drug launched in UK

March 14, 2007 Sales and Marketing Byetta, diabetes

A new diabetes medicine, which mimics the body's natural processes for controlling blood sugar, has been launched in the UK.The …
News

Pharmafocus Europe

March 12, 2007 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Pharmafocus

Pharmafocus Europe is a new publication set to become an indispensable business tool for pharmaceutical industry executives with an interest …
Feature

Shire dispels doubts about New River acquisition

March 12, 2007 Sales and Marketing

Shire has dismissed claims its acquisition of New River Pharmaceuticals is in doubt, after reports that a rival bid for …
News

NICE judges Tarceva too expensive for NHS

March 9, 2007 Sales and Marketing Tarceva, lung cancer

Roche's cancer drug Tarceva has been rejected by NICE for use against the most common form of lung cancer.The watchdog …
News

Trading Places

March 9, 2007 Business Services, Medical Communications, Sales and Marketing AstraZeneca, Athena, public relations, recruitment

Athena Medical PR and AstraZeneca UK have joined forces to undertake a ground-breaking secondment initiative to help build broader expertise …
Feature

PM hints pharma could avoid ‘value-based’ pricing

March 9, 2007 Sales and Marketing PPRS, Tony Blair, value based pricing, value-based pricing

 Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …
News

GSK to test Tycerb for head and neck cancer

March 7, 2007 Sales and Marketing breast cancer

GlaxoSmithKline is to trial its potential blockbuster Tycerb for a new indication in head and neck cancer.Tycerb was only submitted …
News

Eisai prepares for Inovelon UK launch

March 7, 2007 Sales and Marketing

Eisai is preparing to launch its new epilepsy treatment Inovelon in the UK after European regulators approved it in January.Managing …
News

Work begins on Eisai’s Knowledge Centre

March 7, 2007 Research and Development, Sales and Marketing

Eisai is a step nearer to getting its £100 million European base up and running after it broke ground at …
News
The Gateway to Local Adoption Series

Latest content

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026

CeramTec expands German production capacity for orthopaedic ceramics

October 2, 2026

Migraine annual economic and quality-of-life burden in UK

October 1, 2026

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026